able that second response teams concerned in the management of trapped casualties and mass casualty incidents should carry one. The delivery of trauma care in the United Kingdom is currently under review, and the combination of pulse oximetry and trauma scoring at the roadside and later in the accident and emergency department should allow assessment of the effectiveness of immediate care to be made. 
Introduction
After infection with the human immunodeficiency virus (HIV) viral genetic information becomes integrated in the genome of infected cells.' Epidemiological and clinical observations support the hypothesis that the virus may establish a latent infectious state characterised by low viral expression and the absence of a detectable specific antibody response.2 'Moreover, isolation of the virus by coculture techniques in seronegative subjects at risk' suggests that serological analysis is not fully predictive of the infectious state and that infected seronegative people may be a potential source of uncontrolled spread of the virus. Recently high resolution molecular techniques have been described that allow the identification of viral genomes even if only a few copies of integrated or non-integrated viral DNA are present. In situ hybridisation with DNA or RNA (ribonucleic acid) probes gives qualitative information and accurately reflects the distribution of HIV viral genomes at the single cell level.' The polymerase chain reaction technique, a new and sensitive method of gene amplification, allows the selective enrichment of a specific DNA sequence by a factor of 10'.' These techniques might be of particular value in detecting HIV viral sequences when numbers of copies of cloning DNA (cDNA) and RNA per cell are very low.
We report using DNA-DNA, DNA-RNA, and RNA-RNA in situ hybridisation and polymerase chain reactions to identify HIV DNA and RNA in peripheral blood mononuclear cells from seronegative subjects at risk of infection-namely, children born to infected mothers and regular sexual partners of people infected with HIV.
Patients and methods
The study sample consisted of (a) two seronegative women who were regular sexual partners of men infected with HIV (Centers for Disease Control group 3 and 2); (b) a seronegative bisexual man who in the past two years had had sexual intercourse with infected partners; and (c) two seronegative children aged 18 and 24 months born to asymptomatic seropositive mothers. The adult sample was collected from among a cohort of partners of people at risk attending the outpatient clinic of the National Centre for Blood Transfusion, Rome. This particular group was selected on the basis of the frequency of unprotected sexual contact with infected drug addicts. The two children were selected from a group of seronegative infants born to infected mothers and who had a history of impaired growth. All subjects were tested for specific serum antibodies to HIV by a commercial enzyme linked immunosorbent assay (ELISA) (ELAVIA; Pasteur) and by western blot analysis (Pasteur) . Analysis of free antigen in the serum by an antigen capture assay (Abbott) was also performed. Immunological investigations included total T cell count and CD4 and CD8 phenotyping with commercial monoclonal antibodies in a fluorescence activated cell sorter (Becton Dickinson). All the subjects were enrolled for clinical and laboratory follow up and were monitored for more than one year. RNA-RNA in situ hybridisation-By using RNA-RNA in situ hybridisation, which specifically identifies peripheral blood mononuclear cells expressing viral RNA, we confirmed the above findings. Only one subject (case 2) showed no viral RNA ( RNA was lower than that found with the previous technique, being in the range of 1-2/104 cells. Polymerase chain reaction-Four of the five seronegative subjects studied by means of the polymerase chain reaction technique showed a pronounced amplification band, which was further confirmed by Southern blot analysis using the SK70 oligonucleotide probe. All samples were amplified for 30 cycles. two groups and whether this might account for the different immunological reactivities of the two populations.
In conclusion, we believe that in very high risk groups the combined use of in situ hybridisation and gene amplification by polymerase chain reactions is a necessary diagnostic tool for identifying asymptomatic seronegative carriers of HIV-I infection. Furthermore, viral isolation and characterisation will eventually explain whether the lack of immunological recognition in seronegative infected subjects at risk is due to the presence of peculiar viral isolates-for example, defective proviruses-or to a different viral cytotropism, or to both.
